Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-049"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2006-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Seventh framework programme – Nuclear research and training activities (2007-2011) (debate)2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20060613.6.2-049"2
lpv:hasSubsequent	lp_eu:2006-06-13-Speech-2-0502
lpv:speaker	lp:Nikolaos Vakalis2
lpv:spokenAs	member; Delegation to the EU-Romania Joint Parliamentary Committee (2004-09-15--2006-12-31)3,3 member; ITRE (2004-07-21--2007-01-14)3,3 member; EPP-ED (2004-07-20--2009-07-13)3,3 unknown; Nea Dimokratia (2004-07-20--2009-07-13)3,3 substitute; REGI (2004-07-22--2007-01-14)3,3
lpv:translated text	"Mr President, Commissioner, I consider that Parliament has done a very good job. My warmest congratulations to our rapporteur, Mr Buzek. I wish to comment on two amendments already approved by the Committee on Industry, Research and Energy: Amendment 273: this amendment refers to the chapter entitled 'Research infrastructures' and seeks to support excellence in the convergence regions and outermost regions. It quite simply suggests that, in the event of two equally excellent proposals for new research infrastructures, we need to consider which option will contribute more to the strengthening and expansion of the excellence of European research agencies. The fact that, over the period from 2000 to 2006, 50% of public and private money in research went to just 30 of the 254 regions of the European Union bears witness to the fact that excellence is trapped. Amendment 66 on embryonic stem cells. I consider that this amendment is correct both from a philosophical point of view and from the point of view of protecting human rights and respect for human life. In addition, I consider that it is the most correct of the four views on the table, because we cannot set restrictive dates. This is to the detriment of research itself, in that it restricts it to stem cells either of inferior quality or of limited potential and will force our researchers to go to other countries outside the European Union which have stocks of stem cells of these specific dates. We cannot cite subsidiarity and exclude the financing of leading edge research sectors on the grounds that one or some of the Member States prohibit it because, if we take that to its logical conclusion, I would say that it is unfair for countries which prohibit stem cell research to make use of the results from countries which allow it because, in the final analysis, it is certain that adult stem cell research does not suffice for all applications."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph